Halozyme Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. 

CEO
Helen I. Torley
CEOHelen I. Torley
Employees
350
Employees350
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
350
Employees350

HALO Key Statistics

Market cap
7.21B
Market cap7.21B
Price-Earnings ratio
17.02
Price-Earnings ratio17.02
Dividend yield
Dividend yield
Average volume
1.62M
Average volume1.62M
High today
$59.23
High today$59.23
Low today
$57.66
Low today$57.66
Open price
$58.80
Open price$58.80
Volume
1.44M
Volume1.44M
52 Week high
$66.00
52 Week high$66.00
52 Week low
$37.97
52 Week low$37.97

HALO News

Simply Wall St 4d
Halozyme Therapeutics Has A Rock Solid Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankrupt...

Halozyme Therapeutics Has A Rock Solid Balance Sheet

Analyst ratings

56%

of 9 ratings
Buy
55.6%
Hold
44.4%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.